+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver, Thyroid, Kidney, Colorectal and Skin) Cancer, Companies

  • ID: 4849351
  • Report
  • Region: United States
  • 113 Pages
  • Renub Research
1 of 4
The United States Biopsy Market is Expected to Cross US$ 14 Billion Mark by the End of the Year 2025

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • Hologic, Inc
  • Medtronic plc.
  • Olympus Corporation
  • MORE

The biopsy is the procedure to collect the tissues or fluid from the area, which has grown abnormally over a period of time. The sample (tissue or fluid) is further examined through the microscope to check the presence of cancer. Different types of biopsy are done to know cancer, such as vacuum-assisted biopsy, fine-needle aspiration biopsy, and core needle biopsy. For colorectal cancer, colonoscopy or endoscopy is primarily done to check abnormalities, and during the process, abnormal tissues called polyps would collect for biopsy. In the United States, overall cancer incidence is rising, but the cancer death rate is falling over the period of time because of the rise in the number of cancer diagnostics, especially biopsy screening for cancer. United States Biopsy Market is expected to cross US$ 14 Billion mark by the end of the year 2025.

The essential factors that will fuel the market growth are; the rise of an ageing population in the United States, continuous improvement of healthcare infrastructure, rising per capita health care expenditure, increasing per capita income, growing awareness about early detection of cancer by several screenings including biopsy, improvement of diagnostic technologies, etc. Moreover, the rising incidence of cancer in the United States and the increase of less invasive procedures during biopsy will further propel the United States biopsy market in the future course of time.

This report titled “United States Biopsy Market, Volume & Forecast by Segments (Breast, Prostate, Lung, Liver ,Thyroid, Kidney, Colorectal and Skin) Cancer, Companies (C. R. Bard, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Cardinal Health, Inc., Olympus Corporation, FUJIFILM Holdings Corporation, Medtronic plc., Hologic, Inc)” provides a complete analysis of the United States Biopsy Market and Volume.

United States Biopsy Volume Insights - Breast Cancer Biopsy is holding the largest Volume Share

In this report, the researchers have fragmented cancer by biopsy volume into 8 parts; Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Thyroid Cancer, Kidney Cancer, Colorectal Cancer, and Skin Cancer. Breast cancer biopsy is holding the largest volume share of cancer biopsy in the United States. This report provides a multi-factor analysis of why biopsy volume is rising in the United States.

United States Biopsy Market Insights

In this report, the researchers have categorized the biopsy market into 8 parts by cancer type; Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Thyroid Cancer, Kidney Cancer, Colorectal Cancer, and Skin Cancer. For many cancer, more than one biopsy is required to diagnose the patients like colorectal cancer requires at least 6 biopsies. Besides, the publishers have also explained the growth driver and challenges of the biopsy market in the United States.

United States New Cases of Cancer Diagnostic Insights

In this report, the researchers have shown new cancer diagnostic cases and also providing the factor by which cancer prevalence is increasing or decreasing over a period of time.

Segments Covered in the Report

  • Breast Cancer Biopsy
  • Prostate Cancer Biopsy
  • Lung Cancer Biopsy
  • Liver Cancer Biopsy
  • Thyroid Cancer Biopsy
  • Kidney Cancer Biopsy
  • Colorectal Cancer Biopsy
  • Skin Cancer Biopsy

Key Companies Covered in the Report

  • C. R. Bard, Inc.
  • Becton, Dickinson, and Company
  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Olympus Corporation
  • FUJIFILM Holdings Corporation
  • Medtronic plc.
  • Hologic, Inc
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • Hologic, Inc
  • Medtronic plc.
  • Olympus Corporation
  • MORE

1. Introduction

2. Research Methodology

3. Executive Summary

4. United States Biopsy Market & Volume
4.1 Market & Forecast
4.2 Volume & Forecast

5. United States Biopsy Share
5.1 Market Share & Forecast
5.2 Volume Share & Forecast

6. Segment - United States Biopsy Market
6.1 Prostate Cancer Biopsy
6.1.1 Market & Forecast
6.1.2 Volume & Forecast
6.2 Breast Cancer Biopsy
6.2.1 Market & Forecast
6.2.2 Volume & Forecast
6.3 Lung Cancer Biopsy
6.3.1 Market & Forecast
6.3.2 Volume & Forecast
6.4 Liver Cancer Biopsy
6.4.1 Market & Forecast
6.4.2 Volume & Forecast
6.5 Thyroid Cancer Biopsy
6.5.1 Market & Forecast
6.5.2 Volume & Forecast
6.6 Kidney Cancer Biopsy
6.6.1 Market & Forecast
6.6.2 Volume & Forecast
6.7 Colon & Rectum Cancer Biopsy
6.7.1 Market & Forecast
6.7.2 Volume & Forecast
6.8 Melanoma Skin Cancer Biopsy
6.8.1 Market & Forecast
6.8.2 Volume & Forecast

7. Company Analysis
7.1 Becton, Dickinson & Company
7.1.1 Overview
7.1.2 Initiatives & Recent Developments
7.1.3 Mergers & Acquisitions
7.1.4 Revenue
7.2 B. Braun Melsungen AG (Germany)
7.2.1 Overview
7.2.2 Initiatives & Recent Developments
7.2.3 Mergers & Acquisitions
7.2.4 Revenue
7.3 Cardinal Health, Inc.
7.3.1 Overview
7.3.2 Initiatives & Recent Developments
7.3.3 Mergers & Acquisitions
7.3.4 Revenue
7.4 Olympus Corporation (Japan)
7.4.1 Overview
7.4.2 Initiatives & Recent Developments
7.4.3 Mergers & Acquisitions
7.4.4 Revenue
7.5 Boston Scientific Corporation (U.S.)
7.5.1 Overview
7.5.2 Initiatives & Recent Developments
7.5.3 Mergers & Acquisitions
7.5.4 Revenue
7.6 Medtronic Plc.
7.6.1 Overview
7.6.2 Initiatives & Recent Developments
7.6.3 Mergers & Acquisitions
7.6.4 Revenue
7.7 Hologic, Inc.
7.7.1 Overview
7.7.2 Initiatives & Recent Developments
7.7.3 Mergers & Acquisitions
7.7.4 Revenue

8. Growth Factors
8.1 Inadequate Screening Tests for Particular Cancers
8.2 Demand for Minimally-Invasive Biopsy Techniques
8.3 Advancement in Biopsy Techniques

9. Challenges
9.1 Reimbursement Issues
9.2 Limitations

List of Figures:
Figure-01: United States - Biopsy Market (Million US$), 2010 - 2018
Figure-02: United States - Forecast for Biopsy Market (Million US$), 2019 - 2025
Figure-03: United States - Biopsy Volume (Thousands), 2010 - 2018
Figure-04: United States - Forecast for Biopsy Volume (Thousands), 2019 - 2025
Figure-05: United States - Biopsy Market Share (%), 2010 - 2018
Figure-06: United States - Forecast for Biopsy Market Share (%), 2019 - 2025
Figure-07: United States - Biopsy Volume Share (%), 2010 - 2018
Figure-08: United States - Forecast for Biopsy Volume Share (%), 2019 - 2025
Figure-09: United States - Prostate Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-10: United States - Forecast for Prostate Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-11: United States - Prostate Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-12: United States - Forecast for Prostate Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-13: United States - Breast Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-14: United States - Forecast for Breast Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-15: United States - Breast Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-16: United States - Forecast for Breast Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-17: United States - Lung Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-18: United States - Forecast for Lung Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-19: United States - Lung Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-20: United States - Forecast for Lung Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-21: United States - Liver Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-22: United States - Forecast for Liver Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-23: United States - Liver Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-24: United States - Forecast for Liver Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-25: United States - Thyroid Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-26: United States - Forecast for Thyroid Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-27: United States - Thyroid Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-28: United States - Forecast for Thyroid Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-29: United States - Kidney Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-30: United States - Forecast for Kidney Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-31: United States - Kidney Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-32: United States - Forecast for Kidney Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-33: United States - Colon & Rectum Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-34: United States - Forecast for Colon & Rectum Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-35: United States - Colon & Rectum Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-36: United States - Forecast for Colon & Rectum Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-37: United States - Melanoma Skin Cancer Biopsy Market (Million US$), 2010 - 2018
Figure-38: United States - Forecast for Melanoma Skin Cancer Biopsy Market (Million US$), 2019 - 2025
Figure-39: United States - Melanoma Skin Cancer Biopsy Volume (Thousands), 2010 - 2018
Figure-40: United States - Forecast for Melanoma Skin Cancer Biopsy Volume (Thousands), 2019 - 2025
Figure-41: Becton, Dickinson and Company - Revenue (Million US$), 2010 - 2018
Figure-42: Becton, Dickinson, and Company - Forecasted Revenue (Million US$), 2019 - 2025
Figure-43: B. Braun Melsungen AG - Revenue (Million US$), 2011 - 2018
Figure-44: B. Braun Melsungen AG - Forecasted Revenue (Million US$), 2019 - 2025
Figure-45: Cardinal Health, Inc. - Revenue (Billion US$), 2010 - 2018
Figure-46: Cardinal Health, Inc. - Forecasted Revenue (Billion US$), 2019 - 2025
Figure-47: Olympus Corporation - Revenue (Million US$), 2010 - 2018
Figure-48: Olympus Corporation - Forecasted Revenue (Million US$), 2019 - 2025
Figure-49: Boston Scientific Corporation - Revenue (Million US$), 2010 - 2018
Figure-50: Boston Scientific Corporation - Forecasted Revenue (Million US$), 2019 - 2025
Figure-51: Medtronic Plc. - Revenue (Million US$), 2010 - 2018
Figure-52: Medtronic Plc. - Forecasted Revenue (Million US$), 2019 - 2025
Figure-53: Hologic, Inc. - Revenue (Million US$), 2013 - 2018
Figure-54: Hologic, Inc. - Forecasted Revenue (Million US$), 2019 - 2025

List of Tables:
Table 6-1: New Bundled Codes for Breast Biopsy with Image Guidance
Table 6-2: Breast Biopsy - Final Medicare Physician Fee Schedule, 2015

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation (U.S.)
  • C. R. Bard, Inc.
  • Cardinal Health, Inc.
  • FUJIFILM Holdings Corporation
  • Hologic, Inc
  • Medtronic plc.
  • Olympus Corporation
Note: Product cover images may vary from those shown
5 of 4

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll